APA (7th ed.) Citation

R, B., M, P., S, P., T, B., F, D., E, E., . . . S, G. (2025). Synergistic Cancer Metabolic Therapy via Co-Delivery of 3-Bromopyruvate and Temozolomide with a Supramolecular Shuttle. ACS applied materials & interfaces, 17(44), 60342. https://doi.org/10.1021/acsami.5c17607

Chicago Style (17th ed.) Citation

R, Bellavita, et al. "Synergistic Cancer Metabolic Therapy via Co-Delivery of 3-Bromopyruvate and Temozolomide with a Supramolecular Shuttle." ACS Applied Materials & Interfaces 17, no. 44 (2025): 60342. https://doi.org/10.1021/acsami.5c17607.

MLA (9th ed.) Citation

R, Bellavita, et al. "Synergistic Cancer Metabolic Therapy via Co-Delivery of 3-Bromopyruvate and Temozolomide with a Supramolecular Shuttle." ACS Applied Materials & Interfaces, vol. 17, no. 44, 2025, p. 60342, https://doi.org/10.1021/acsami.5c17607.